Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 8;8(35):58765-58770.
doi: 10.18632/oncotarget.17679. eCollection 2017 Aug 29.

MicroRNA expression levels as diagnostic biomarkers for intraductal papillary mucinous neoplasm

Lei Wang #  1 , Jianming Zheng #  2 , Chang Sun #  1 , Li Wang  3 , Gang Jin  4 , Lei Xin  1 , Zhendong Jin  1 , Dong Wang  1 , Zhaoshen Li  1
Affiliations

MicroRNA expression levels as diagnostic biomarkers for intraductal papillary mucinous neoplasm

Lei Wang et al. Oncotarget. .

Abstract

Intraductal papillary mucinous neoplasms (IPMNs) are deadly exocrine mucinous tumors. Currently the molecular features and diagnostic markers of IPMNs are not well understood. In this study, we performed microRNA (miRNA) profiling assays to study the potential roles of miRNAs in IPMNs using 78 cases of IPMN patients and controls. When comparing the miRNA expression between IPMN patient samples and controls, we found that miR-210, miR-223, miR-221, miR-155 and miR-187 were differentially expressed in normal pancreas and IPMNs. We further studied the miRNA expression profiles in different pancreatic diseases and identified miRNA features that are associated with Chronic pancreatitis (CP), IPMN, and Pancreatic ductal adenocarcinoma (PDAC). Therefore, these miRNAs might serve as new risk biomarkers of IPMN and could be useful for future targeted therapies.

Keywords: cancer diagnosis; intraductal papillary mucinous neoplasms (IPMNs); miRNA.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1. MicroRNA expression profiles in IPMN patient samples
miRNA expression levels were determined by SYBR Green I base quantitative PCR. Briefly, RNA samples were in vitro transcribed in to cDNA using miRNA specific stem-loop RT primers, the the RT products were used for the real time PCR analysis. The expression of individual miRNAs were normalized to Let-7a using 2-ΔCt method. N=3.
Figure 2
Figure 2. Differential miRNA expression between IPMN and NP samples
The relative expression levels of miR-155 and miR-210 were determined by real time PCR analysis using IPMS and NP samples.
See this image and copyright information in PMC

References

    1. Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788–97. - PMC - PubMed
    1. Del Chiaro M, Verbeke C. Intraductal papillary mucinous neoplasms of the pancreas: reporting clinically relevant features. Histopathology. 2017;70:850–60. doi: 10.1111/his.13131. - DOI - PubMed
    1. Nara S, Shimada K, Kosuge T, Kanai Y, Hiraoka N. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Am J Surg Pathol. 2008;32:243–55. doi: 10.1097/PAS.0b013e3181484f1e. - DOI - PubMed
    1. Nara S, Onaya H, Hiraoka N, Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases. Pancreas. 2009;38:8–16. doi: 10.1097/MPA.0b013e318181b90d. - DOI - PubMed
    1. Lin S, Choe J, Du P, Triboulet R, Gregory RI. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 2016;62:335–45. doi: 10.1016/j.molcel.2016.03.021. - DOI - PMC - PubMed

LinkOut - more resources